Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe revision label in the site footer changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing detailed study content with a minimal error screen and a Home link. This indicates an access issue that prevents users from viewing the trial record as intended.SummaryDifference19%

- Check30 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 in the Study Documents section, indicating an updated protocol/documentation. This change reflects a newer version of the study protocol and related documents linked on the page.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page's revision label was updated to v3.6.6, signaling a minor metadata/patch update to the page without changes to the study details.SummaryDifference0.0%

- Check51 days agoChange DetectedAn NIH grant/contract identifier for 2018 was added to the study's list of identifiers, indicating NIH support for the trial.SummaryDifference0.0%

- Check58 days agoChange DetectedThe Plain Language Summary section has been removed from the Study Details page, eliminating the lay-friendly overview of the trial.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.